(PUK) Prudential - Overview
Exchange: NYSE •
Country: Hong Kong •
Currency: USD •
Type: Common Stock •
ISIN: US74435K2042
Stock: Life Insurance, Health Insurance, Asset Management, Savings, Investments
Total Rating 60
Risk 24
Buy Signal -0.71
| Risk 5d forecast | |
|---|---|
| Volatility | 30.5% |
| Relative Tail Risk | 2.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.71 |
| Alpha | 38.41 |
| Character TTM | |
|---|---|
| Beta | 0.922 |
| Beta Downside | 1.823 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.19% |
| CAGR/Max DD | 0.14 |
Description: PUK Prudential March 06, 2026
Prudential plc (PUK) is an insurance and asset management company operating in Asia and Africa.
The company offers life and health insurance, savings, investments, wealth management, and foreign exchange services. The insurance sector is characterized by long-term liabilities and capital-intensive operations.
Founded in 1848, PUK is headquartered in Hong Kong. Its business model focuses on providing financial protection and wealth accumulation products.
For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Asian middle-class growth fuels insurance product demand
- Regulatory changes impact Chinese market access
- Investment performance directly affects asset management fees
- Exchange rate fluctuations influence reported earnings
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 3.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.63 > 1.0 |
| NWC/Revenue: 63.55% < 20% (prev 62.15%; Δ 1.40% < -1%) |
| CFO/TA 0.02 > 3% & CFO 3.62b > Net Income 3.53b |
| Net Debt (-310.0m) to EBITDA (13.43b): -0.02 < 3 |
| Current Ratio: 4.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.31b) vs 12m ago -4.49% < -2% |
| Gross Margin: 85.83% > 18% (prev 0.37%; Δ 8.55k% > 0.5%) |
| Asset Turnover: 12.22% > 50% (prev 5.24%; Δ 6.98% > 0%) |
| Interest Coverage Ratio: 57.62 > 6 (EBITDA TTM 13.43b / Interest Expense TTM 241.0m) |
Altman Z'' 1.25
| A: 0.07 (Total Current Assets 18.51b - Total Current Liabilities 4.35b) / Total Assets 199.12b |
| B: 0.06 (Retained Earnings 12.05b / Total Assets 199.12b) |
| C: 0.08 (EBIT TTM 13.89b / Avg Total Assets 182.29b) |
| D: 0.07 (Book Value of Equity 12.22b / Total Liabilities 179.68b) |
| Altman-Z'' Score: 1.25 = BB |
Beneish M 1.00
| DSRI: 14.91 (Receivables 2.21b/57.8m, Revenue 22.28b/8.67b) |
| GMI: 0.43 (GM 85.83% / 37.25%) |
| AQI: 0.94 (AQ_t 0.90 / AQ_t-1 0.96) |
| SGI: 2.57 (Revenue 22.28b / 8.67b) |
| TATA: -0.00 (NI 3.53b - CFO 3.62b) / TA 199.12b) |
| Beneish M-Score: 9.00 (Cap -4..+1) = D |
What is the price of PUK shares?
As of March 14, 2026, the stock is trading at USD 29.82 with a total of 598,930 shares traded.
Over the past week, the price has changed by -1.56%, over one month by -2.35%, over three months by -0.07% and over the past year by +53.21%.
Over the past week, the price has changed by -1.56%, over one month by -2.35%, over three months by -0.07% and over the past year by +53.21%.
Is PUK a buy, sell or hold?
Prudential has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy PUK.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PUK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39 | 30.7% |
| Analysts Target Price | 39 | 30.7% |
PUK Fundamental Data Overview March 11, 2026
P/E Trailing = 11.3697
P/E Forward = 13.5501
P/S = 2.7554
P/B = 2.0061
P/EG = 1.3283
Revenue TTM = 22.28b USD
EBIT TTM = 13.89b USD
EBITDA TTM = 13.43b USD
Long Term Debt = 4.48b USD (from longTermDebt, last quarter)
Short Term Debt = 500.0m USD (from shortTermDebt, last quarter)
Debt = 5.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -310.0m USD (from netDebt column, last quarter)
Enterprise Value = 36.99b USD (36.76b + Debt 5.33b - CCE 5.10b)
Interest Coverage Ratio = 57.62 (Ebit TTM 13.89b / Interest Expense TTM 241.0m)
EV/FCF = 11.47x (Enterprise Value 36.99b / FCF TTM 3.22b)
FCF Yield = 8.72% (FCF TTM 3.22b / Enterprise Value 36.99b)
FCF Margin = 14.47% (FCF TTM 3.22b / Revenue TTM 22.28b)
Net Margin = 15.86% (Net Income TTM 3.53b / Revenue TTM 22.28b)
Gross Margin = 85.83% ((Revenue TTM 22.28b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.19 (Enterprise Value 36.99b / Total Assets 199.12b)
Interest Expense / Debt = 1.65% (Interest Expense 87.7m / Debt 5.33b)
Taxrate = 20.39% (351.0m / 1.72b)
NOPAT = 11.06b (EBIT 13.89b * (1 - 20.39%))
Current Ratio = 4.25 (Total Current Assets 18.51b / Total Current Liabilities 4.35b)
Debt / Equity = 0.29 (Debt 5.33b / totalStockholderEquity, last quarter 18.12b)
Debt / EBITDA = -0.02 (Net Debt -310.0m / EBITDA 13.43b)
Debt / FCF = -0.10 (Net Debt -310.0m / FCF TTM 3.22b)
Total Stockholder Equity = 17.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.94% (Net Income 3.53b / Total Assets 199.12b)
RoE = 20.30% (Net Income TTM 3.53b / Total Stockholder Equity 17.40b)
RoCE = 63.46% (EBIT 13.89b / Capital Employed (Equity 17.40b + L.T.Debt 4.48b))
RoIC = 50.08% (NOPAT 11.06b / Invested Capital 22.08b)
WACC = 8.30% (E(36.76b)/V(42.09b) * Re(9.31%) + D(5.33b)/V(42.09b) * Rd(1.65%) * (1-Tc(0.20)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.52%
[DCF] Terminal Value 77.08% ; FCFF base≈3.22b ; Y1≈3.24b ; Y5≈3.46b
[DCF] Fair Price = 45.95 (EV 57.50b - Net Debt -310.0m = Equity 57.81b / Shares 1.26b; r=8.30% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: -4.59 | EPS CAGR: -1.57% | SUE: 4.0 | # QB: 1
Revenue Correlation: 2.51 | Revenue CAGR: 22.49% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=2.31 | Chg7d=-0.058 | Chg30d=-0.058 | Revisions Net=-1 | Growth EPS=+18.7% | Growth Revenue=+10.1%
P/E Forward = 13.5501
P/S = 2.7554
P/B = 2.0061
P/EG = 1.3283
Revenue TTM = 22.28b USD
EBIT TTM = 13.89b USD
EBITDA TTM = 13.43b USD
Long Term Debt = 4.48b USD (from longTermDebt, last quarter)
Short Term Debt = 500.0m USD (from shortTermDebt, last quarter)
Debt = 5.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -310.0m USD (from netDebt column, last quarter)
Enterprise Value = 36.99b USD (36.76b + Debt 5.33b - CCE 5.10b)
Interest Coverage Ratio = 57.62 (Ebit TTM 13.89b / Interest Expense TTM 241.0m)
EV/FCF = 11.47x (Enterprise Value 36.99b / FCF TTM 3.22b)
FCF Yield = 8.72% (FCF TTM 3.22b / Enterprise Value 36.99b)
FCF Margin = 14.47% (FCF TTM 3.22b / Revenue TTM 22.28b)
Net Margin = 15.86% (Net Income TTM 3.53b / Revenue TTM 22.28b)
Gross Margin = 85.83% ((Revenue TTM 22.28b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.19 (Enterprise Value 36.99b / Total Assets 199.12b)
Interest Expense / Debt = 1.65% (Interest Expense 87.7m / Debt 5.33b)
Taxrate = 20.39% (351.0m / 1.72b)
NOPAT = 11.06b (EBIT 13.89b * (1 - 20.39%))
Current Ratio = 4.25 (Total Current Assets 18.51b / Total Current Liabilities 4.35b)
Debt / Equity = 0.29 (Debt 5.33b / totalStockholderEquity, last quarter 18.12b)
Debt / EBITDA = -0.02 (Net Debt -310.0m / EBITDA 13.43b)
Debt / FCF = -0.10 (Net Debt -310.0m / FCF TTM 3.22b)
Total Stockholder Equity = 17.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.94% (Net Income 3.53b / Total Assets 199.12b)
RoE = 20.30% (Net Income TTM 3.53b / Total Stockholder Equity 17.40b)
RoCE = 63.46% (EBIT 13.89b / Capital Employed (Equity 17.40b + L.T.Debt 4.48b))
RoIC = 50.08% (NOPAT 11.06b / Invested Capital 22.08b)
WACC = 8.30% (E(36.76b)/V(42.09b) * Re(9.31%) + D(5.33b)/V(42.09b) * Rd(1.65%) * (1-Tc(0.20)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.52%
[DCF] Terminal Value 77.08% ; FCFF base≈3.22b ; Y1≈3.24b ; Y5≈3.46b
[DCF] Fair Price = 45.95 (EV 57.50b - Net Debt -310.0m = Equity 57.81b / Shares 1.26b; r=8.30% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: -4.59 | EPS CAGR: -1.57% | SUE: 4.0 | # QB: 1
Revenue Correlation: 2.51 | Revenue CAGR: 22.49% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=2.31 | Chg7d=-0.058 | Chg30d=-0.058 | Revisions Net=-1 | Growth EPS=+18.7% | Growth Revenue=+10.1%